التفاصيل البيبلوغرافية
| العنوان: |
Nanoplatforms: The future of oral cancer treatment. |
| المؤلفون: |
Senevirathna, Kalpani, Jayawickrama, Shalindu M., Jayasinghe, Yovanthi A., Prabani, Karunakalage I. P., Akshala, Kushani, Pradeep, Ratupaskatiye G. G. R., Damayanthi, Hewaratne D. W. T., Hettiarachchi, Kalani, Dorji, Thinley, Lucero‐Prisno, Don E., Rajapakse, Rajapakse M. G., Kanmodi, Kehinde K., Jayasinghe, Ruwan D. |
| المصدر: |
Health Science Reports; Aug2023, Vol. 6 Issue 8, p1-18, 18p |
| مستخلص: |
Background and Aims: Cytotoxicity is a key disadvantage of using chemotherapeutic drugs to treat cancer. This can be overcome by encapsulating chemotherapeutic drugs in suitable carriers for targeted delivery, allowing them to be released only at the cancerous sites. Herein, we aim to review the recent scientific developments in the utilization of nanotechnology‐based drug delivery systems for treating oral malignancies that can lead to further improvements in clinical practice. Methods: A comprehensive literature search was conducted on PubMed, Google Scholar, ScienceDirect, and other notable databases to identify recent peer‐reviewed clinical trials, reviews, and research articles related to nanoplatforms and their applications in oral cancer treatment. Results: Nanoplatforms offer a revolutionary strategy to overcome the challenges associated with conventional oral cancer treatments, such as poor drug solubility, non‐specific targeting, and systemic toxicity. These nanoscale drug delivery systems encompass various formulations, including liposomes, polymeric nanoparticles, dendrimers, and hydrogels, which facilitate controlled release and targeted delivery of therapeutic agents to oral cancer sites. By exploiting the enhanced permeability and retention effect, Nanoplatforms accumulate preferentially in the tumor microenvironment, increasing drug concentration and minimizing damage to healthy tissues. Additionally, nanoplatforms can be engineered to carry multiple drugs or a combination of drugs and diagnostic agents, enabling personalized and precise treatment approaches. Conclusion: The utilization of nanoplatforms in oral cancer treatment holds significant promise in revolutionizing therapeutic strategies. Despite the promising results in preclinical studies, further research is required to evaluate the safety, efficacy, and long‐term effects of nanoformulations in clinical settings. If successfully translated into clinical practice, nanoplatform‐based therapies have the potential to improve patient outcomes, reduce side effects, and pave the way for more personalized and effective oral cancer treatments. Highlights: Surgery, radiation, and chemotherapy are the solely available treatments for cancer.Oral cancer includes cancers of the mouth and the back of the throat.With selective targeting and distribution of these anticancer medications to tumor tissues, nanotechnology has traditionally been used in cancer therapy to enhance pharmacokinetics and lower the systemic toxicity of chemotherapy.Nanotechnology has the potential to overcome many shortcomings of chemotherapy, enable drugs to precisely target tumor cells, reduce unfavorable side effects on nearby healthy tissues, and thus pave the way to create cutting‐edge treatments for oral cancer. [ABSTRACT FROM AUTHOR] |
|
Copyright of Health Science Reports is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder